Agile Therapeutics: Q4 Earnings Insights
Agile Therapeutics: Q4 Earnings Insights
Agile Therapeutics (OTC:AGRX) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM.
Agile Therapeutics（场外交易代码：AGRX）于2024年3月28日星期四上午8点05分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Agile Therapeutics missed estimated earnings by -59.0%, reporting an EPS of $-1.46 versus an estimate of $-0.92.
Agile Therapeutics报告每股收益为-1.46美元，未达到预期收益-59.0％，而估计为-0.92美元。
Revenue was down $381 thousand from the same period last year.
收入比去年同期下降了38.1万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.37 which was followed by a 2.0% drop in the share price the next day.
上个季度，该公司的每股收益高出0.37美元，随后第二天股价下跌了2.0％。
Here's a look at Agile Therapeutics's past performance:
以下是敏捷疗法过去的表现：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.84 | -3.48 | -7.50 | -11.5 |
| EPS Actual | -1.47 | -3.10 | -7.76 | -9 |
| Revenue Estimate | 5.27M | 4.68M | 3.40M | 3.08M |
| Revenue Actual | 6.66M | 5.50M | 3.81M | 4.00M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -1.84 | -3.48 | -7.50 | -11.5 |
| 实际每股收益 | -1.47 | -3.10 | -7.76 | -9 |
| 收入估算 | 5.27 米 | 4.68 亿 | 3.40 米 | 3.08 米 |
| 实际收入 | 6.66 米 | 5.50 米 | 3.81 亿 | 4.00M |
To track all earnings releases for Agile Therapeutics visit their earnings calendar here.
要追踪Agile Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。